A US appeals court decided to revive the case against Nintendo Co. for claims that its Wii, Wii U, and Switch controllers violated a data-transmission patent.
A federal judge in Seattle misinterpreted the patent when it concluded that Nintendo's controllers did not infringe on Genuine Enabling Technology LLC's patent, according to the US Court of Appeals for the Federal Circuit.
Genuine Enabling Technology (GET) holds a patent for "combining data streams" to reduce computer resource usage.
In 2017, GET filed a lawsuit against Nintendo, alleging that the way its controllers communicate with its videogame systems infringes on the patent.
In 2020, a federal court in Seattle found in favor of Nintendo, interpreting GET's patent to include devices that transmit data signals at greater frequencies than Nintendo's controllers.
On Friday, a three-judge Federal Circuit panel reversed the ruling and remanded the case to the lower court, stating that the lower court misinterpreted GET's patent when clearing Nintendo of the claims.
The appeals court also held that the district court erred in giving too much weight to Nintendo's expert testimony, emphasizing that "intrinsic evidence" should be prioritized when interpreting patents.
To review GET's claims based on the appeals court's reading of the patent term, the Federal Circuit remanded the matter to the lower court.


CK Hutchison Unit Launches Arbitration Against Panama Over Port Concessions Ruling
Global PC Makers Eye Chinese Memory Chip Suppliers Amid Ongoing Supply Crunch
Australian Scandium Project Backed by Richard Friedland Poised to Support U.S. Critical Minerals Stockpile
Nvidia CEO Jensen Huang Says AI Investment Boom Is Just Beginning as NVDA Shares Surge
Jerome Powell Attends Supreme Court Hearing on Trump Effort to Fire Fed Governor, Calling It Historic
Minnesota Judge Rejects Bid to Halt Trump Immigration Enforcement in Minneapolis
Missouri Judge Dismisses Lawsuit Challenging Starbucks’ Diversity and Inclusion Policies
FDA Targets Hims & Hers Over $49 Weight-Loss Pill, Raising Legal and Safety Concerns
U.S. Lawmakers to Review Unredacted Jeffrey Epstein DOJ Files Starting Monday
Court Allows Expert Testimony Linking Johnson & Johnson Talc Products to Ovarian Cancer
AMD Shares Slide Despite Earnings Beat as Cautious Revenue Outlook Weighs on Stock
Sony Q3 Profit Jumps on Gaming and Image Sensors, Full-Year Outlook Raised
Instagram Outage Disrupts Thousands of U.S. Users
TrumpRx Website Launches to Offer Discounted Prescription Drugs for Cash-Paying Americans
Ford and Geely Explore Strategic Manufacturing Partnership in Europe
Newly Released DOJ Epstein Files Expose High-Profile Connections Across Politics and Business 



